---
schema_version: "secwatch.filing_event.v1"
accession: "0001486957-26-000041"
form_type: "8-K"
ticker: "BWXT"
cik: "0001486957"
company_name: "BWX Technologies, Inc."
filed_at: "2026-08-03T20:28:58+00:00"
generated_at: "2026-08-03T20:30:05.191684+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BWXT Q2 revenue $901.6M (+18% YoY), GAAP EPS $0.97, raises FY2026 guidance

## Summary
- Q2 revenue $901.6M (+18% YoY); Government Ops $601.3M (+2%), Commercial Ops $302.5M (+72%).
- GAAP net income $89.1M ($0.97 diluted EPS); non-GAAP EPS $1.07, adjusted EBITDA $155.5M (+7%).
- Announced sale of medical business to focus on nuclear national defense and commercial power.
- Closed acquisition of Precision Components Group on July 1, 2026, adding U.S. commercial nuclear manufacturing.
- Raised FY2026 guidance: adjusted EBITDA $662M-$672M, non-GAAP EPS $4.70-$4.80, FCF $345M-$360M.

## SEC filing metadata
- accession: 0001486957-26-000041
- form_type: 8-K
- ticker: BWXT
- cik: 0001486957
- company_name: BWX Technologies, Inc.
- filed_at: 2026-08-03T20:28:58+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1486957/000148695726000041/0001486957-26-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1486957/000148695726000041/bwxt_63026x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001486957-26-000041
- JSON: https://secwatch.observer/filing/0001486957-26-000041.json
- Plain text: https://secwatch.observer/filing/0001486957-26-000041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.